VAERS Explorer
Back to explore

Report #2849805

Received Jul 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
76 yrs
State
MA
Recovered
Unknown
Vaccinated
Jul 10, 2025
Onset
Jul 10, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDTD ADSORBED (TENIVAC)SANOFI PASTEURUNK2CA81C1OT / LA

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

inappropriate use due to administration of an expired vaccine with no reported adverse event; Initial information received on 11-Jul-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 76-year-old female patient and is reported inappropriate use due to administration of an expired diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Tenivac] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 10-Jul-2025, the patient received a Booster dose 0.5 ml of suspect Diphtheria-2/Tetanus-5 Adsorbed Toxoids No Preservative Adult Suspension for injection of lot 2CA81C1 and expiry date: 04-Jul-2025 via intramuscular route in the left deltoid for immunization had inappropriate use due to administration of an expired vaccine with no reported adverse event (expired product administered) (latency: on same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.